As more higher‐stage patients are included, the HR for predicting BCR in PCa decreases; however, patients diagnosed with pathological stage T3‐4 are prone to undergo more aggressive treatment, such as chemical therapy and anti‐androgen therapy (ADT), after surgery. Here, BCR is linked to posterior cortical atrophy.